These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 30892982

  • 1. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
    Ling YL, Huang X, Mitri G, Lovelace B, Pham A, Knobler R, Li X, Gao X.
    J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
    [Abstract] [Full Text] [Related]

  • 2. Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019.
    Girardi M, Carlson K, Huang X, Corman SL, Edmundson P, Schmier J, Kale HP, Raina R, Foss F.
    J Dermatolog Treat; 2024 Dec; 35(1):2360568. PubMed ID: 38852942
    [Abstract] [Full Text] [Related]

  • 3. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL, Dunbar NM, Meehan KR, Szczepiorkowski ZM, Lansigan F.
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [Abstract] [Full Text] [Related]

  • 4. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
    Alfred A, Taylor PC, Dignan F, El-Ghariani K, Griffin J, Gennery AR, Bonney D, Das-Gupta E, Lawson S, Malladi RK, Douglas KW, Maher T, Guest J, Hartlett L, Fisher AJ, Child F, Scarisbrick JJ.
    Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
    [Abstract] [Full Text] [Related]

  • 5. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G, Carabelli A, Berti E, Guizzardi M, Fossati S, De Filippo C, Bertani E.
    Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
    [Abstract] [Full Text] [Related]

  • 6. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma.
    Seremet S, Abhyankar S, Herd TJ, Aires D.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1212-1216. PubMed ID: 27741338
    [Abstract] [Full Text] [Related]

  • 7. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
    Shiue LH, Couturier J, Lewis DE, Wei C, Ni X, Duvic M.
    Photodermatol Photoimmunol Photomed; 2015 Jul 01; 31(4):184-94. PubMed ID: 25772268
    [Abstract] [Full Text] [Related]

  • 8. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb 01; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [Abstract] [Full Text] [Related]

  • 9. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.
    Lagacé F, Netchiporouk E, Turchin I, Gulliver W, Dutz J, Kirchhof MG, Popradi P, Gniadecki R, Lynde C, Litvinov IV.
    Skin Therapy Lett; 2022 Sep 01; 27(5):1-6. PubMed ID: 36469458
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
    Owsianowski M, Garbe C, Ramaker J, Orfanos CE, Gollnick H.
    Hautarzt; 1996 Feb 01; 47(2):114-23. PubMed ID: 8868455
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T4, M0) Cutaneous T-Cell Lymphoma in the Australian Setting.
    Peacock A, Dehle F, Mesa Zapata OA, Prince HM, Gennari F, Taylor C.
    Value Health; 2022 Jun 01; 25(6):965-974. PubMed ID: 35667784
    [Abstract] [Full Text] [Related]

  • 15. Extracorporeal photopheresis--a new approach for the treatment of cutaneous T cell lymphomas.
    Gollnick HP, Owsianowski M, Ramaker J, Chun SC, Orfanos CE.
    Recent Results Cancer Res; 1995 Jun 01; 139():409-15. PubMed ID: 7597308
    [Abstract] [Full Text] [Related]

  • 16. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
    Quaglino P, Comessatti A, Ponti R, Peroni A, Mola F, Fierro MT, Savoia P, Novelli M, Bernengo MG.
    Int J Immunopathol Pharmacol; 2009 Jun 01; 22(2):353-62. PubMed ID: 19505389
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.